Compare EVAX & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | MKTW |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 38.7M |
| IPO Year | 2021 | N/A |
| Metric | EVAX | MKTW |
|---|---|---|
| Price | $5.85 | $16.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $12.33 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 98.3K | 8.0K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 5.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.55 |
| Revenue | $7,650,000.00 | ★ $342,206,000.00 |
| Revenue This Year | $128.77 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.27 |
| Revenue Growth | ★ 132.17 | N/A |
| 52 Week Low | $1.20 | $9.08 |
| 52 Week High | $12.15 | $21.74 |
| Indicator | EVAX | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 46.89 |
| Support Level | $5.72 | $16.20 |
| Resistance Level | $6.70 | $16.65 |
| Average True Range (ATR) | 0.47 | 0.37 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 50.26 | 8.33 |
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.